This “rare” autism-linked genetic disorder may be far more common than scientists thought
A major analysis suggests Phelan-McDermid syndrome, a genetic disorder closely linked to autism, may affect about 1 in 7,300 people and more than 45,000 Americans. Researchers warn that thousands of cases may remain hidden because genetic testing is often not performed, even as t
The recent analysis on Phelan-McDermid syndrome has significant implications for the field of genetics and autism research. As a genetic disorder closely linked to autism, understanding the prevalence of Phelan-McDermid syndrome is crucial for developing effective diagnostic and treatment strategies. The estimated frequency of 1 in 7,300 people and over 45,000 Americans with the condition highlights the need for increased awareness and genetic testing.
The fact that thousands of cases may remain hidden due to limited genetic testing is a pressing concern. This underscores the importance of incorporating genetic testing into standard diagnostic protocols, particularly for individuals with autism or autism-like symptoms. As the field of genetics continues to evolve, it is essential for professionals to stay up-to-date on the latest research and testing methods to ensure accurate diagnoses and effective treatment plans.
As the medical community moves forward, it will be essential to monitor the development of new diagnostic tools and testing protocols for Phelan-McDermid syndrome. Additionally, researchers and clinicians should investigate the underlying genetic mechanisms driving the condition and explore potential therapeutic interventions. For certification professionals, staying current on the latest research and guidelines will be vital in providing high-quality care and support for individuals affected by Phelan-McDermid syndrome and autism.
Originally reported by sciencedaily.com. CertificationNews adds analysis for science & discovery readers.